| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| Other Sizes |
|
| ln Vitro |
P62-mediated inducer of mitophagy (10 μM; 0, 1, 3, 6, 24 hours) stabilizes Nrf2, and increases P62 expression (10 μM; 9 hours) to initiate mitophagy [1]. In MEFs, PINK1/Parkin signaling pathway is downstreamly acted upon by P62-mediated mitophagy (10 μM; 24 hours) [1]. Polyubiquitination and conjugation within the mitochondria are positively impacted by P62-mediated mitophagy inducers [1].
|
|---|---|
| Cell Assay |
RT-PCR[1]
Cell Types: MEF Tested Concentrations: 10 µM Incubation Duration: 9 hrs (hours) Experimental Results: Significant increase in p62 mRNA levels. Immunofluorescence[1] Cell Types: MEF Tested Concentrations: 10 µM Incubation Duration: 24 hrs (hours) Experimental Results: Demonstration that induction of P62 mitochondrial recruitment is Parkin-independent. Western Blot Analysis[1] Cell Types: MEF Tested Concentrations: 10 µM Incubation Duration: 0, 1, 3, 6, 24 hrs (hours) Experimental Results: Nrf2 levels reached maximum after 6 hrs (hours) and remained elevated at 24 hrs (hours). |
| References |
| Molecular Formula |
C14H9IN4O2
|
|---|---|
| Molecular Weight |
392.151334524155
|
| Exact Mass |
391.977
|
| CAS # |
1809031-84-2
|
| PubChem CID |
122190591
|
| Appearance |
Light yellow to yellow solid powder
|
| LogP |
3.5
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
21
|
| Complexity |
379
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
N1(C2=CC=CC(I)=C2)C=C(C2=CC=CC([N+]([O-])=O)=C2)N=N1
|
| InChi Key |
LSVWEYNSNZJEGB-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C14H9IN4O2/c15-11-4-2-5-12(8-11)18-9-14(16-17-18)10-3-1-6-13(7-10)19(20)21/h1-9H
|
| Chemical Name |
1-(3-iodophenyl)-4-(3-nitrophenyl)triazole
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~8.33 mg/mL (~21.24 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.25 mg/mL (3.19 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.25 mg/mL (3.19 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.5500 mL | 12.7502 mL | 25.5004 mL | |
| 5 mM | 0.5100 mL | 2.5500 mL | 5.1001 mL | |
| 10 mM | 0.2550 mL | 1.2750 mL | 2.5500 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
